Cargando…

Effects of Dexmedetomidine on Immunomodulation and Pain Control in Videolaparoscopic Cholecystectomies: A Randomized, Two-Arm, Double-Blinded, Placebo-Controlled Trial

Aim: Digital and robotic technology applications in laparoscopic surgery have revolutionized routine cholecystectomy. Insufflation of the peritoneal space is vital for its safety but comes at the cost of ischemia-reperfusion-induced intraabdominal organ compromise before the return of physiologic fu...

Descripción completa

Detalles Bibliográficos
Autores principales: Silva, Gustavo Nascimento, Brandão, Virna Guedes, Perez, Marcelo Vaz, Lewandrowski, Kai-Uwe, Fiorelli, Rossano Kepler Alvim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10141731/
https://www.ncbi.nlm.nih.gov/pubmed/37109010
http://dx.doi.org/10.3390/jpm13040622
_version_ 1785033448961867776
author Silva, Gustavo Nascimento
Brandão, Virna Guedes
Perez, Marcelo Vaz
Lewandrowski, Kai-Uwe
Fiorelli, Rossano Kepler Alvim
author_facet Silva, Gustavo Nascimento
Brandão, Virna Guedes
Perez, Marcelo Vaz
Lewandrowski, Kai-Uwe
Fiorelli, Rossano Kepler Alvim
author_sort Silva, Gustavo Nascimento
collection PubMed
description Aim: Digital and robotic technology applications in laparoscopic surgery have revolutionized routine cholecystectomy. Insufflation of the peritoneal space is vital for its safety but comes at the cost of ischemia-reperfusion-induced intraabdominal organ compromise before the return of physiologic functions. Dexmedetomidine in general anesthesia promotes controlling the response to trauma by altering the neuroinflammatory reflex. This strategy may improve clinical outcomes in the postoperative period by reducing postoperative narcotic use and lowering the risk of subsequent addiction. In this study, the authors aimed to evaluate dexmedetomidine’s therapeutic and immunomodulatory potential on perioperative organ function. Methods: Fifty-two patients were randomized 1:1: group A—sevoflurane and dexmedetomidine (dexmedetomidine infusion [1 µg/kg loading, 0.2–0.5 µg/kg/h maintenance dose]), and group B—sevoflurane with saline 0.9% infusion as a placebo control. Three blood samples were collected: preoperatively (T0 h), 4–6 h after surgery (T4–6 h), and 24 h postoperatively (T24 h). The primary outcome was the level analysis of inflammatory and endocrine mediators. Secondary outcome measures were the time to return to normal preoperative hemodynamic parameters, spontaneous ventilation, and postoperative narcotic requirements to control surgical pain. Results: A reduction of Interleukin 6 was found at 4–6 h after surgery in group A with a mean of 54.76 (27.15–82.37; CI 95%) vs. 97.43 (53.63–141.22); p = 0.0425) in group B patients. Systolic and diastolic blood pressure and heart rate were lower in group A patients, who also had a statistically significantly lower opioid consumption in the first postoperative hour when compared to group B patients (p < 0.0001). We noticed a similar return to spontaneous ventilation pattern in both groups. Conclusions: Dexmedetomidine decreased interleukin-6 4–6 h after surgery, likely by providing a sympatholytic effect. It provides good perioperative analgesia without respiratory depression. Implementing dexmedetomidine during laparoscopic cholecystectomy has a good safety profile and may lower healthcare expenditure due to faster postoperative recovery.
format Online
Article
Text
id pubmed-10141731
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-101417312023-04-29 Effects of Dexmedetomidine on Immunomodulation and Pain Control in Videolaparoscopic Cholecystectomies: A Randomized, Two-Arm, Double-Blinded, Placebo-Controlled Trial Silva, Gustavo Nascimento Brandão, Virna Guedes Perez, Marcelo Vaz Lewandrowski, Kai-Uwe Fiorelli, Rossano Kepler Alvim J Pers Med Article Aim: Digital and robotic technology applications in laparoscopic surgery have revolutionized routine cholecystectomy. Insufflation of the peritoneal space is vital for its safety but comes at the cost of ischemia-reperfusion-induced intraabdominal organ compromise before the return of physiologic functions. Dexmedetomidine in general anesthesia promotes controlling the response to trauma by altering the neuroinflammatory reflex. This strategy may improve clinical outcomes in the postoperative period by reducing postoperative narcotic use and lowering the risk of subsequent addiction. In this study, the authors aimed to evaluate dexmedetomidine’s therapeutic and immunomodulatory potential on perioperative organ function. Methods: Fifty-two patients were randomized 1:1: group A—sevoflurane and dexmedetomidine (dexmedetomidine infusion [1 µg/kg loading, 0.2–0.5 µg/kg/h maintenance dose]), and group B—sevoflurane with saline 0.9% infusion as a placebo control. Three blood samples were collected: preoperatively (T0 h), 4–6 h after surgery (T4–6 h), and 24 h postoperatively (T24 h). The primary outcome was the level analysis of inflammatory and endocrine mediators. Secondary outcome measures were the time to return to normal preoperative hemodynamic parameters, spontaneous ventilation, and postoperative narcotic requirements to control surgical pain. Results: A reduction of Interleukin 6 was found at 4–6 h after surgery in group A with a mean of 54.76 (27.15–82.37; CI 95%) vs. 97.43 (53.63–141.22); p = 0.0425) in group B patients. Systolic and diastolic blood pressure and heart rate were lower in group A patients, who also had a statistically significantly lower opioid consumption in the first postoperative hour when compared to group B patients (p < 0.0001). We noticed a similar return to spontaneous ventilation pattern in both groups. Conclusions: Dexmedetomidine decreased interleukin-6 4–6 h after surgery, likely by providing a sympatholytic effect. It provides good perioperative analgesia without respiratory depression. Implementing dexmedetomidine during laparoscopic cholecystectomy has a good safety profile and may lower healthcare expenditure due to faster postoperative recovery. MDPI 2023-04-01 /pmc/articles/PMC10141731/ /pubmed/37109010 http://dx.doi.org/10.3390/jpm13040622 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Silva, Gustavo Nascimento
Brandão, Virna Guedes
Perez, Marcelo Vaz
Lewandrowski, Kai-Uwe
Fiorelli, Rossano Kepler Alvim
Effects of Dexmedetomidine on Immunomodulation and Pain Control in Videolaparoscopic Cholecystectomies: A Randomized, Two-Arm, Double-Blinded, Placebo-Controlled Trial
title Effects of Dexmedetomidine on Immunomodulation and Pain Control in Videolaparoscopic Cholecystectomies: A Randomized, Two-Arm, Double-Blinded, Placebo-Controlled Trial
title_full Effects of Dexmedetomidine on Immunomodulation and Pain Control in Videolaparoscopic Cholecystectomies: A Randomized, Two-Arm, Double-Blinded, Placebo-Controlled Trial
title_fullStr Effects of Dexmedetomidine on Immunomodulation and Pain Control in Videolaparoscopic Cholecystectomies: A Randomized, Two-Arm, Double-Blinded, Placebo-Controlled Trial
title_full_unstemmed Effects of Dexmedetomidine on Immunomodulation and Pain Control in Videolaparoscopic Cholecystectomies: A Randomized, Two-Arm, Double-Blinded, Placebo-Controlled Trial
title_short Effects of Dexmedetomidine on Immunomodulation and Pain Control in Videolaparoscopic Cholecystectomies: A Randomized, Two-Arm, Double-Blinded, Placebo-Controlled Trial
title_sort effects of dexmedetomidine on immunomodulation and pain control in videolaparoscopic cholecystectomies: a randomized, two-arm, double-blinded, placebo-controlled trial
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10141731/
https://www.ncbi.nlm.nih.gov/pubmed/37109010
http://dx.doi.org/10.3390/jpm13040622
work_keys_str_mv AT silvagustavonascimento effectsofdexmedetomidineonimmunomodulationandpaincontrolinvideolaparoscopiccholecystectomiesarandomizedtwoarmdoubleblindedplacebocontrolledtrial
AT brandaovirnaguedes effectsofdexmedetomidineonimmunomodulationandpaincontrolinvideolaparoscopiccholecystectomiesarandomizedtwoarmdoubleblindedplacebocontrolledtrial
AT perezmarcelovaz effectsofdexmedetomidineonimmunomodulationandpaincontrolinvideolaparoscopiccholecystectomiesarandomizedtwoarmdoubleblindedplacebocontrolledtrial
AT lewandrowskikaiuwe effectsofdexmedetomidineonimmunomodulationandpaincontrolinvideolaparoscopiccholecystectomiesarandomizedtwoarmdoubleblindedplacebocontrolledtrial
AT fiorellirossanokepleralvim effectsofdexmedetomidineonimmunomodulationandpaincontrolinvideolaparoscopiccholecystectomiesarandomizedtwoarmdoubleblindedplacebocontrolledtrial